7 studies on Neuroinflammation mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research highlights the critical role of early monocyte modulation in influencing the trajectory of Alzheimer's disease (AD) pathology. The findings suggest that ARA 290 could represent a novel therapeutic strate…
These promising preclinical results for NeuroPep-X represent a significant step forward in the development of disease-modifying therapies for Alzheimer's Disease. The observed reductions in amyloid plaques and neuroin…
These findings highlight dehydroepiandrosterone sulfate (DHEAS) as a promising neurosteroid with significant neuroprotective properties against amyloid-beta-induced pathology. The ability of DHEAS to preserve choliner…
This research is significant because it identifies NeuroPep-X as a potential novel therapeutic agent with a dual mechanism of action, addressing both the behavioral symptoms of depression and its underlying neurobiolo…
This comprehensive review provides a critical roadmap for future Alzheimer's disease research, consolidating vast amounts of data into actionable insights and identifying key areas for therapeutic focus. It underscore…
This research highlights SS-31's novel mechanism of action in neuroprotection, specifically by targeting microglial ferroptosis and modulating their inflammatory state. The ability to shift microglia towards a protect…